Works matching IS 13520504 AND DT 2008 AND VI 15 AND IP 6

Results: 11

The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium.

Published in:

Journal of Viral Hepatitis, 2008, v. 15, n. 6, p. 399, doi. 10.1111/j.1365-2893.2007.00950.x

By:

Matheï, C.;
Van Dooren, S.;
Lemey, P.;
Van Damme, P.;
Buntinx, F.;
Vandamme, A.-M.

Publication type:

Article

Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.

Published in:

Journal of Viral Hepatitis, 2008, v. 15, n. 6, p. 434, doi. 10.1111/j.1365-2893.2007.00957.x

By:

Papatheodoridis, G. V.;
Chrysanthos, N.;
Hadziyannis, E.;
Cholongitas, E.;
Manesis, E. K.

Publication type:

Article

Hepatitis C in ethnic minority populations in England.

Published in:

Journal of Viral Hepatitis, 2008, v. 15, n. 6, p. 421, doi. 10.1111/j.1365-2893.2007.00958.x

By:

Mann, A. G.;
Trotter, C. L.;
Balogun, M. Adekoyejo;
Ramsay, M. E.

Publication type:

Article

Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.

Published in:

Journal of Viral Hepatitis, 2008, v. 15, n. 6, p. 459, doi. 10.1111/j.1365-2893.2008.00959.x

By:

Yu, H.;
Babiuk, L. A.;
Van Drunen Littel-Van Den Hurk, S.

Publication type:

Article

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.

Published in:

Journal of Viral Hepatitis, 2008, v. 15, n. 6, p. 442, doi. 10.1111/j.1365-2893.2007.00960.x

By:

Loggi, E.;
Gramenzi, A.;
Margotti, M.;
Cursaro, C.;
Galli, S.;
Vitale, G.;
Grandini, E.;
Scuteri, A.;
Vukotic, R.;
Andreone, P.;
Bernardi, M.

Publication type:

Article

Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.

Published in:

Journal of Viral Hepatitis, 2008, v. 15, n. 6, p. 427, doi. 10.1111/j.1365-2893.2007.00962.x

By:

De Lédinghen, V.;
Barreiro, P.;
Foucher, J.;
Labarga, P.;
Castéra, L.;
Vispo, M. E.;
Bernard, P.-H.;
Martin-Carbonero, L.;
Neau, D.;
García-Gascó, P.;
Merrouche, W.;
Soriano, V.

Publication type:

Article

HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.

Published in:

Journal of Viral Hepatitis, 2008, v. 15, n. 6, p. 409, doi. 10.1111/j.1365-2893.2007.00963.x

By:

Ruys, T. A.;
Nanlohy, N. M.;
Van Den Berg, C. H. S. B.;
Hassink, E.;
Beld, M.;
Van De Laar, T.;
Bruisten, S.;
Wit, F.;
Krol, A.;
Prins, M.;
Lange, J.;
Van Baarle, D.

Publication type:

Article

A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China.

Published in:

Journal of Viral Hepatitis, 2008, v. 15, n. 6, p. 449, doi. 10.1111/j.1365-2893.2008.00967.x

By:

Zhu, L.;
Tse, C. -H.;
Wong, V. W. -S.;
Chim, A. M. -L.;
Leung, K. -S.;
Chan, H. L. -Y.

Publication type:

Article

Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?

Published in:

2008

By:

Aghemo, Alessio;
Rumi, Maria Grazia;
Colombo, Massimo

Publication type:

Letter

FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.

Published in:

2008

By:

Poynard, T.;
Munteanu, M.;
Ngo, Y.;
Moussalli, J.;
Lebray, P.;
Thabut, D.;
Benhamou, Y.;
Ratziu, V.

Publication type:

Letter

Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.

Published in:

2008

By:

Sebastiani, G.;
Vario, A.;
Guido, M.;
Alberti, A.

Publication type:

Letter